The implication of giant tumor size on surgical resection, oncological, and functional outcomes in craniopharyngioma

Pituitary. 2020 Oct;23(5):515-525. doi: 10.1007/s11102-020-01053-z.

Abstract

Objective: Implication of the tumor size on oncological and functional outcomes of craniopharyngioma is inconsistently reported. The aim of this study is to assess the postoperative outcome of giant craniopharyngiomas (> 4 cm in diameter) and to elucidate the impact of tumor size on various outcome parameters and survival.

Material and methods: Forty-four patients (children aged ≤ 18 years: 25; adults: 16) with giant craniopharyngioma, operated between January 2001 and December 2015, were included in this study. Various outcomes, progression-free survival (PFS) and overall survival (OS) were calculated.

Results: Gross total resection (GTR) was achieved in 17 (39%) and subtotal resection (STR) in 27 (61%) patients. Eleven patients (25%) received radiotherapy (RT) after STR. Postoperatively, new cranial nerve and motor deficits were noted in 12 (27%) and 9 (20%) patients, respectively. Tumor recurrence following GTR and STR without adjuvant RT was diagnosed in 3 (17%), and 5 (38%) patients, respectively. Following STR with RT, one (9%) experienced recurrence. PFS at 5-, and 10- year following GTR, STR, and STR + RT was 80.8%, 45.4%, and 90%, respectively. At 5- and 10- year, OS was 86.5%, 77.9% and 100% following GTR, STR, and STR + RT, respectively. The rate of GTR was significantly lower in patients with giant tumors (39% vs. 62%; Chi-square test, p value 0.008). Postoperatively, neurological deficit (20%), hypopituitarism (95%) and hypothalamic dysfunction (26%) were significantly higher for giant craniopharyngiomas. Hazards of recurrence were not significant between giant and non-giant tumors (hazard ratio 1.86; 95% CI 0.94-3.68; p 0.07). There was no significant difference in OS between the patients with giant and non-giant tumors (log-rank test 2.1; p value 0.14).

Conclusion: Tumor size should be considered as an important predictor of the postoperative functional outcome. Although the rate of GTR is less than that of small tumors, the recurrence rate, progression-free survival, and overall survival of the patients with giant tumor are comparable to non-giant tumors.

Keywords: Craniopharyngioma; Extent of resection; Functional outcome; Giant tumor; Tumor recurrence.

MeSH terms

  • Craniopharyngioma / mortality
  • Craniopharyngioma / pathology*
  • Craniopharyngioma / surgery*
  • Disease-Free Survival
  • Female
  • Humans
  • Hypopituitarism / mortality
  • Hypopituitarism / pathology
  • Hypopituitarism / surgery
  • Hypothalamic Diseases / mortality
  • Hypothalamic Diseases / pathology
  • Hypothalamic Diseases / surgery
  • Male
  • Postoperative Period
  • Progression-Free Survival
  • Retrospective Studies
  • Treatment Outcome